Frozen Shoulder Research

Current scientific research on frozen shoulder (adhesive capsulitis) has undergone a significant shift during the past several years. Historically, frozen shoulder was viewed primarily as a mechanical problem involving adhesions and stiffness within the shoulder capsule. Modern research now describes the condition as a complex interaction between inflammation, fibrosis, immune system activity, metabolic health, genetics, and altered movement patterns. Researchers increasingly recognize that frozen shoulder is not simply a shoulder joint disorder but a multifactorial condition influenced by systemic health factors and local tissue responses. Studies by Ji-Young Kim and colleagues have highlighted that frozen shoulder appears to involve genetic susceptibility, systemic inflammation, and localized tissue injury rather than a purely mechanical restriction process. Their recent reviews suggest that the disease develops through an interaction of inflammatory and fibrotic pathways that progressively alter the capsule surrounding the glenohumeral joint.

One of the most influential areas of current research concerns the biological mechanisms responsible for capsular fibrosis. Earlier theories proposed that inflammation eventually produced adhesions and scar tissue. More recent work by Tom Kraal and colleagues has expanded this understanding by identifying elevated inflammatory cytokines, fibroblast proliferation, transformation of fibroblasts into contractile myofibroblasts, and excessive deposition of collagen within the shoulder capsule. These researchers describe frozen shoulder as a process resembling other fibrotic disorders in the body. Instead of normal tissue remodeling, the capsule becomes increasingly thickened, contracted, and less elastic. This fibrotic process explains why patients often lose external rotation first and eventually develop restrictions in multiple planes of movement.

Recent investigations by Sergio Navarro-Ledesma and colleagues have proposed an even broader perspective. Their 2024 work suggests that frozen shoulder may exist in different subtypes. They propose that primary frozen shoulder may be strongly associated with metabolic dysfunction, insulin resistance, and systemic inflammatory changes, whereas secondary frozen shoulder following trauma or rotator cuff injury may involve more localized orthopedic mechanisms. This emerging model is important because it suggests that two patients with similar stiffness may have different underlying drivers of disease progression. Such findings are encouraging researchers to move beyond a one-size-fits-all treatment approach.

Researchers continue to investigate why frozen shoulder is strongly associated with diabetes. Numerous studies have demonstrated that individuals with diabetes develop frozen shoulder at substantially higher rates than the general population and often experience more severe symptoms and prolonged recovery. Recent reviews examining diabetic populations suggest that chronic hyperglycemia may contribute to abnormal collagen cross-linking, increased fibrosis, and exaggerated inflammatory responses within the capsule. Researchers studying diabetic adhesive capsulitis have proposed that advanced glycation end-products may alter tissue elasticity and promote persistent stiffness. This connection has strengthened the theory that frozen shoulder is not merely an orthopedic condition but may represent a musculoskeletal manifestation of systemic metabolic dysfunction.

Current pathophysiology research has also focused on the rotator interval and coracohumeral ligament. Investigators have found that these structures frequently become thickened and contracted during the disease process. Recent reviews by Alomari and colleagues emphasize that pathological changes in these tissues contribute significantly to motion loss, particularly external rotation. Rather than simple adhesion formation, modern imaging and histological studies suggest a progressive capsular contracture involving multiple structures surrounding the joint. This finding has influenced both rehabilitation and surgical approaches, as clinicians increasingly target specific capsular regions rather than viewing the shoulder capsule as a uniform structure.

Another major research trend involves understanding the inflammatory phase of frozen shoulder. Traditional models described a predictable progression through freezing, frozen, and thawing stages. New evidence suggests that these stages may overlap and vary considerably between individuals. Ji-Young Kim and colleagues have reported that inflammatory markers remain elevated longer than previously believed, while fibrosis may begin earlier in the disease process than classical models suggest. This has led researchers to question whether frozen shoulder follows a strictly linear progression. Instead, some patients may experience simultaneous inflammatory and fibrotic changes. Such findings may explain why treatment responses vary dramatically among individuals.

Researchers are also reexamining long-held beliefs about the natural history of frozen shoulder. For decades, clinicians were taught that most cases eventually resolve completely. More recent follow-up studies have challenged this assumption. Several investigations indicate that a significant percentage of patients continue to demonstrate residual stiffness, strength deficits, or functional limitations years after diagnosis. Contemporary researchers argue that although many patients improve substantially, complete restoration of motion is not guaranteed. This shift has encouraged earlier intervention and more individualized management strategies rather than relying solely on spontaneous recovery.

Treatment research has become increasingly sophisticated. Historically, physical therapy focused heavily on aggressive stretching and mobilization. Modern evidence suggests that overly aggressive interventions during highly irritable stages may actually exacerbate symptoms. Researchers now advocate matching treatment intensity to tissue irritability and disease stage. Current rehabilitation studies emphasize gradual restoration of mobility, symptom-guided exercise progression, and management of pain rather than forcing range of motion. This represents a major departure from earlier treatment philosophies that emphasized breaking adhesions through forceful stretching.

The role of manual therapy continues to be investigated. Contemporary research generally supports combining manual techniques with exercise rather than using either intervention alone. Researchers examining multimodal treatment approaches have found that patients often achieve better outcomes when manual therapy, exercise, education, and pain management strategies are integrated. Current evidence suggests that manual therapy may help reduce pain, improve comfort, and facilitate movement, but it is unlikely to reverse capsular fibrosis independently. These findings are particularly relevant to massage therapists and manual therapists who commonly encounter patients with frozen shoulder.

Injection therapy remains another active research area. Corticosteroid injections continue to demonstrate benefit during early painful stages by reducing inflammation and improving short-term function. However, researchers are investigating alternatives including hydrodilatation, platelet-rich plasma, and biologic therapies. Studies continue to compare these approaches, although evidence remains mixed. The emerging trend is not necessarily finding a superior injection but determining which patients respond best to specific interventions based on disease stage and underlying pathology.

A particularly interesting development concerns watchful waiting. Research presented by Bilal Sohail Siddiq and colleagues found that a carefully monitored watchful-waiting strategy produced outcomes similar to formal physical therapy at one year in some patient populations, while reducing healthcare costs. These findings do not suggest that therapy is unnecessary but highlight the importance of patient education and realistic expectations regarding recovery timelines. Researchers increasingly emphasize shared decision-making and individualized treatment selection.

Basic science researchers continue exploring molecular targets that may eventually lead to new treatments. Ji-Young Kim and colleagues have investigated genetic influences, inflammatory signaling pathways, and fibrotic mediators involved in disease progression. Their work suggests that future therapies may focus on interrupting fibrosis before severe capsular contracture develops. Investigators are examining transforming growth factor-beta pathways, cytokine signaling, and myofibroblast activity as potential therapeutic targets. Although these discoveries remain largely experimental, they provide valuable insight into why frozen shoulder develops and persists.

For manual therapists, perhaps the most important lesson from current research is that frozen shoulder is increasingly viewed as a biological and systemic disorder rather than a simple mechanical restriction. Contemporary evidence supports assessing metabolic health, diabetes status, thyroid disorders, sleep disturbance, pain sensitivity, and overall functional limitations alongside shoulder mobility. Researchers now describe frozen shoulder as a condition involving inflammation, fibrosis, altered tissue remodeling, and systemic influences that interact over time. Treatment appears most effective when it combines education, pain management, gradual movement restoration, appropriate exercise, and realistic expectations rather than focusing solely on stretching a stiff joint. The modern scientific view is therefore much broader than earlier models and continues to evolve as researchers uncover new details about the inflammatory and fibrotic mechanisms underlying this challenging condition.